Metrics as of 10/15/2026, 05:43 AM (Berlin time), refresh in progress.
Anteris Technologies Global Stock
Anteris Technologies Global Corp.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Wayne Geoffrey Paterson
- Employees
- 174
- Market cap
- $609 M
- IPO
- 13/12/2024
Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering…
Anteris Technologies Global stock: price history
1D
-2.9%
1W
-8.2%
1M
-28.2%
6M
-0.5%
YTD
+25.5%
1Y
+37.0%
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
11/11/2026 (in 25 days)
Volatility around earnings
~18% weaker price swings than usual
Anteris Technologies Global stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 04/08/2026.
Ask the agents about Anteris Technologies Global
Analyst assessment of Anteris Technologies Global
PRICE TARGET LOW
US$10.00
CONSENSUS
US$10.00
MEDIAN
US$10.00
PRICE TARGET HIGH
US$10.00
0
STRONG BUY
2
BUY
0
HOLD
0
SELL
0
STRONG SELL
2
TOTAL · Buy
As of: 14/10/2026
Anteris Technologies Global stock metrics
P/E
-2.27
P/B
2.42
EV/EBITDA
-3.52
RETURN ON EQUITY
-11.6%
NET MARGIN
-2,884.3%
DEBT/EQUITY
0.01
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
62.1%
FLOAT SHARES
60,353,139
AVG. DAILY VOLUME (30D)
1,059,883
Insider transactions (SEC)
L1 Capital Pty Ltd
L1 Capital Pty Ltd
L1 Capital Pty Ltd
L1 Capital Pty Ltd
L1 Capital Pty Ltd
Institutional holders
Comparable stocks
Frequently asked questions about Anteris Technologies Global stock
What does Anteris Technologies Global do?
Anteris Technologies Global Corp. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Wayne Geoffrey Paterson, the company employs around 174 people.
The IPO was on 13/12/2024; the stock trades on NASDAQ under the ticker AVR.
What do analysts say about Anteris Technologies Global stock?
2 analysts rate the stock, the consensus is Buy (as of 14/10/2026).
The average price target is US$10.00, ranging from US$10.00 to US$10.00, with a median of US$10.00.
This is an external assessment, not a statement by Market Jury.
When does Anteris Technologies Global report next?
The next earnings date is 11/11/2026.
Around past earnings, price swings were roughly -18% stronger than usual.
Does Anteris Technologies Global pay a dividend?
No, Anteris Technologies Global currently does not pay a dividend.
Which stocks are comparable to Anteris Technologies Global?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Anteris Technologies Global stock analyzed?
Clicking "Analyze stock" lets five strategies assess Anteris Technologies Global against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.